Forxiga CKD Japan Post-Marketing Surveillance (PMS)

Trial Identifier:	D169AC00007
Sponsor:	AstraZeneca
Start Date:	April 2022
Primary Completion Date:	October 2024
Study Completion Date:	October 2024
Condition:	Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Ishikawa, Japan
Japan	Nara, Japan
Japan	Shiga, Japan
Japan	Yamanashi, Japan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.